Transforming growth factors-β protect primary rat hippocampal neuronal cultures from degeneration induced by β-amyloid peptide

Brain Research

Volumn 732, Issue 1-2, 1996, Pages 16-24

  Ren, Renée Feng ^a   Flanders, Kathleen Corey ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Alzheimer's disease; neuroblastoma cell line; neuroprotection; primary hippocampal neuron; transforming growth factor ; amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN; NEUROPROTECTIVE AGENT; TRANSFORMING GROWTH FACTOR BETA1;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE DEGENERATION; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030565544     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00458-1     Document Type: Article

References (41)

1. Bottenstein J.H., Sato G.H. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci USA. 76:1979;514-517.
2. Busciglio J., Lorenzo A., Yankner B.A. Methodological variables in the assesment of beta amyloid neurotoxicity. Neurobiol. Aging. 13:1992;609-612.
3. Chalazonitis A., Kalberg J., Twardzik D.R., Morrison R.S., Kessler J.A. Transforming growth factor β has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor. Dev. Biol. 152:1992;121-132.
4. Chao C.C., Hu S., Kravitz F.H., Tsang M., Anderson W.R., Peterson P.K. Transforming growth factor-β protects human neurons against β-amyloid-induced injury. Mol. Chem. Neuropathol. 23:1994;159-178.
5. Danielpour D., Kim K.Y., Dart L.L., Watanabe S., Roberts A.B., Sporn M.B. Sandwich enzyme-linked immunosorbent assay (SELISAs) quantitate and distinguish two forms of transforming growth factor (TGF-beta 1 and TGF-beta 2) in complex biological fluids. Growth Factors. 2:1989;61-71.
6. Finch C.E., Laping N.J., Morgan T.E., Nichols N.R., Pasinetti G.M. TGF-β1 is an organizer of responses to neurodegeneration. J. Cell. Biochem. 53:1993;314-332.
7. Flanders K.C., Lippa C.F., Smith T.W., Pollen D.A., Sporn M.B. Altered expression of transforming growth factor-β in Alzheimer's disease. Neurology. 45:1995;1561-1569.
8. Flanders K.C., Ludecke G., Engels S., Cissel D.S., Roberts A.B., Kondaiah P., Lafyatis R., Sporn M.B., Unsicker K. Localization and actions of transforming growth factors-β in the embryonic nervous system. Development. 113:1991;183-191.
9. Flanders K.C., Ludecke G., Renzing J., Hamm C., Cissel D.S., Unsicker K. Effects of TGF-βs and bFGF in astroglial cell growth and gene expression in vitro. Mol. Cell. Neurosci. 4:1993;406-417.
10. Frautschy S.A., Baird A., Cole G.M. Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA. 88:1991;8362-8366.
11. Games D., Adams D., Alessandrini R., Barbour B., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavzia M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
12. Gray C.W., Patal A.J. Regulation of β-amyloid precursor protein isoform mRNAs by transforming growth factor-β1 and interleukin-1β in astrocytes. Brain Res. Mol. Brain Res. 19:1993;261-266.
13. Graycar J.L., Miller D.A., Arrick B.A., Lyons R.M., Moses H.L., Derynck R. Human transforming growth factor-β3: recombinant expression, purification and biological activities in comparison with transforming growth factor-β1 and β2. Mol. Endocrinol. 7:1989;1977-1986.
14. Gross C.E., Bednar M.M., Howard D.B., Sporn M.B. Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke. 24:1993;558-562.
15. Gruppuso P.A., Mikumo R., Brautigan D.L., Braun L. Growth arrest induced by transforming growth factor β1 is accompanied by protein phosphatase activation in human keratinocytes. J. Biol. Chem. 266:1991;3444-3448.
16. Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/ cell kill. J. Immunol. Methods. 119:1989;203-210.
17. Klempt N.D., Sirimanne E., Gunn A.J., Klempt M., Singh K., Williams C., Gluckman P.D. Hypoxia-ischemia induces transforming growth factor β1 mRNA in the infant rat brain. Mol. Brain Res. 13:1992;93-101.
18. Kowall N.W., Beal M.F., Busciglio J., Duffy L.K., Yanker B.A. An in vivo model for the neurodegeneration effects of β-amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA. 88:1991;7247-7251.
19. Kowall N.W., Mckee A.C., Yankner B.A., Beal M.F. In vivo neurotoxicity of beta-amyloid [β(1-40)] and the β(25-35) fragment. Neurobiol. Aging. 13:1992;537-542.
20. + toxicity. EMBO J. 14:1995;736-742.
21. Logan A., Frautschy S.A., Gonzalez A.-M., Sporn M.B., Baird A. Enhanced expression of transforming growth factor β1 in the rat brain after a localized cerebral injury. Brain Res. 587:1992;216-225.
22. Lowe, S.L., Francis, P.T., Procter, A.W., Palmer, A.M., Davison, A.N. and Bowen, D.M., Gamma-aminobutyric acid concentration at two stages of Alzheimer's disease, Brain, (1988) 785-799.
23. Lyons R.M., Moses H.L. Transforming growth factors and the regulation of cell proliferation. Eur. J. Biochem. 187:1990;467-473.
24. Martinou J.C., Le Van Thai A., Velette A., Weber M.J. Transforming growth factor β1 is a potent survival factor for rat embryo motoneurons in culture. Dev. Brain Res. 52:1990;175-181.
25. McNeill H., Williams C., Guan J., Dragunow M., Lawlor P., Sirimanne E., Nikolics K., Gluckman P. Neuronal rescue with transforming growth factor-β1 after hypoxic-ischaemic brain injury. NeuroReport. 5:1994;901-904.
26. Morgan T.E., Nichols N.R., Pasinetti G.M., Finch C.E. TGF-β1 mRNA increases in macrophages/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp. Neurol. 120:1993;291-301.
27. Monning U., Sandbrink R., Banati R.B., Masters C.L., Beyreuther Transforming growth factor β mediates increase of mature transmembrane amyloid precursor protein in microglial cells. FASEB Lett. 342:1994;267-272.
28. Pike C.J., Burdick D., Walencewicez A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
29. Pike C.J., Cotman C.W. Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid. Neuroscience. 56:1993;269-274.
30. Pike C.J., Cumming S B.J., Cotman C.W. β-amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. NeuroReport. 3:1992;769-772.
31. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
32. Prehn J.H.M., Backhauss C., Krieglstein J. Transforming growth factor-β prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neurocortex from ischemic injury in vivo. J. Cerebral Blood Flow Metab. 13:1993;521-525.
33. Prehn J.H.M., Bindokas V.P., Marcuccilli C.J. Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampal neurons. Proc. Natl. Acad. Sci. USA. 91:1994;12599-12603.
34. Prehn J.H.M., Peruche B., Unsicker K., Krieglstein J. Isoform-specific effects of transforming growth factors-β on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J. Neurochem. 60:1993;1665-1672.
35. Roberts, A.B. and Sporn, M.B. The transforming growth factors-β. In M.B. Sporn and A.B. Roberts (Eds.), Handbook of Experimental Pharmacology, Peptide Growth Factors and Their Receptors I, Vol. 95, Springer, Heidelberg, pp. 419-472.
36. Rush D.K., Aschmies S., Merriman M.C. Intracerebral β-amyloid (25-35) produces tissue damage: is it neurotoxic? Neurobiol. Aging. 13:1992;591-594.
37. Unsicker K., Flanders K.C., Cissel D.S., Lafyatis R., Sporn M.B. Transforming growth factor beta isoforms in the adult rat central and periperal nervous systems. Neuroscience. 44:1991;613-625.
38. Van der Wal E.A., Gómez-Pinilla F., Cotman C.W. Transforming growth factor-β1 is in plaques in Alzheimer's and Down's pathologies. NeuroReport. 4:1993;69-72.
39. Vodovotz, Y., Lucia, M.S., Flanders, K.C., Chesler, L., Smith, T.W., Weidner, J., Mumford, R., Nathan, C., Roberts, A.B., Lippa, C.F. and Sporn, M.B., Tangle-bearing neurons in brains of patients with Alzheimer's disease are immunoreactive for inducible nitric oxide synthase, J. Exp. Med., submitted.
40. Waite J., Cole G.M., Frautschy S.A., Connor D.J., Thal L.J. Solvent effects on beta protein toxicity in vivo. Neurobiol. Aging. 13:1992;595-599.
41. Wolozin B., Hirashima N., Luo Y.Q., Li Y.H., Alkon D.L., Etcheberrigaray R., Sunderland T. Transforming growth factor β induces Aβ-responsive calcium fluxes in neurons. Neuroreport. 10:1995;1429-1433.